Cross-Market Price Comparison
| Other Listed Market | Shanghai (SSE) — 东阳光 |
|---|---|
| Other Market Stock Code | 600673 |
| H-Share Offer Price | To be extracted |
| Other Market Price | Loading... |
| Reference Exchange Rate | Loading... |
| H-Share Offer Price Premium/Discount vs Other Market | Loading... |
Company Overview
| Stock Name | 宜昌東陽光長江藥業股份有限公司 - Ｈ股 |
|---|---|
| Stock Code | 01558 |
| Company Full Name | 宜昌東陽光長江藥業股份有限公司 - Ｈ股 |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國從事藥品生產及銷售。 |
| Listing Date | 2015-12-29 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國湖北省宜昌宜都市濱江路38號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.hec-changjiang.com |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 15.00 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 9.1% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 135,198,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 14.54 |
|---|---|
| First Day Open | HK$ 15.0 |
| First Day Change | -3.07% |
| First Day Volume | 16172600.0 |
| First Day Turnover | 238113000.0 |
Use of Proceeds
| Use of Proceeds | 1、約44.8%所得款項凈額，或約605.6百萬港元（人民幣500百萬元），用于在宜都基地三號地興建新口服制劑生產工廠； 2、約12.6%所得款項凈額，或約170.2百萬港元（人民幣140.5百萬元），用于在宜都基地三號地興建新胰島素生產工廠； 3、約28.2%所得款項凈額，或約354.1百萬港元（人民幣292.3百萬元），用于現有及未來產品的推廣及營銷活動，包括學術推廣、廣告及贊助、出版營銷及推廣數據、擴充及建立專門針對我們產品的隊伍以及對我們的產品進行市場調研； 4、約10%所得款項凈額，或約125.6百萬港元（人民幣103.7百萬元）將用作營運資金及一般企業用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (3)
中国国际金融香港证券有限公司 CE AEN894
工商国际金融有限公司
招银国际融资有限公司 CE AVM940
Joint Bookrunners (6)
中国国际金融香港证券有限公司 CE AEN894
工商国际金融有限公司
招银国际融资有限公司 CE AVM940
农银国际融资有限公司 CE AWL249
建银国际金融有限公司 CE AJO225
Nomura International (Hong Kong) Limited CE AAF742
Joint Lead Managers (6)
中国国际金融香港证券有限公司 CE AEN894
工商国际金融有限公司
招银国际融资有限公司 CE AVM940
农银国际融资有限公司 CE AWL249
建银国际金融有限公司 CE AJO225
Nomura International (Hong Kong) Limited CE AAF742
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Ally Bridge LB-Sunshine Limited | 139,680,000 HKD | — | 2.10% | — | 6 months | 2016-06-29 |
| 2 | 保银资产管理有限公司 | 170,520,000 HKD | — | 2.50% | — | 6 months | 2016-06-29 |
| 3 | 南方龙腾基金 | 77,514,000 HKD | — | 1.10% | — | 6 months | 2016-06-29 |
| 4 | 三星电气(香港)有限公司 | 232,545,000 HKD | — | 3.40% | — | 6 months | 2016-06-29 |
Directors & Management
| Chairman | 唐新發 |
|---|---|
| Company Secretary | 彭琪云;黃偉超 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 廣東東陽光藥業有限公司(51.4%);毛杰(18.35%) |
|---|
